Cardona-Huerta, Servando

Overview

I am a Medical Physician MD, with a specialty in General Surgery and Oncology Surgery, with a Doctorate degree in Medicine, at the University of Heidelberg, Germany, and the German Cancer Research Center (DKFZ). Clinical Fellowship at the Breast Unit, Karolinska Institute, Stockholm, Sweden. Postdoctoral at California Pacific Medical Center, San Francisco California, USA. Medical Coordinator of the Seguro Popular program TecSalud (2010-2020). National Director of Clinical Research TecSalud. 2015 to date. Member of the National System of Researchers CONACYT Mexico.

Publications
Research
Teaching
Background
Contact
View All

selected publications

academic article in scopus
- COVID-19 classification using thermal images. Journal of Biomedical Optics. 27. 2022
- Spatial interaction between breast cancer and environmental pollution in the Monterrey Metropolitan Area. Heliyon. 7. 2021
- Rapid improvement of a critically ill obstetric patient with SARS-CoV-2 infection after administration of convalescent plasma. International Journal of Gynecology and Obstetrics. 152:439-441. 2021
- Value of a breast imaging unit in the detection of breast cancer in Mexico. ecancermedicalscience. 15. 2021
- Does axillary lymph node size predict better metastatic involvement than apparent diffusion coefficient (ADC) value in women with newly diagnosed breast cancer?. Acta Radiologica. 61:1494-1504. 2020
- Immunotyping of tumor¿infiltrating lymphocytes in triple¿negative breast cancer and genetic characterization. Oncology Letters. 20. 2020
- Comparison of characteristics in Mexican women with breast cancer according to healthcare coverage. Women's Health. 16. 2020
- Genetic alterations of triple negative breast cancer (TNBC) in women from northeastern Mexico. Oncology Letters. 17:3581-3588. 2019
- Resources for the attention of patients with breast cancer in Mexico. Gaceta Mexicana de Oncologia. 18:27-32. 2019
- A solitary presentation of panniculitis in a patient with a history of breast cancer. Annals of Medicine and Surgery. 36:54-57. 2018
- Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer. PLoS ONE. 13. 2018
- Apparent Diffusion Coefficient Value to Evaluate Tumor Response After Neoadjuvant Chemotherapy in Patients with Breast Cancer. Academic Radiology. 25:179-187. 2018
- Joven & fuerte": Program for young Women with Breast Cancer in Mexico - Initial Results. Revista de Investigacion Clinica. 69:223-228. 2017
- A new gene expression signature for Triple-Negative breast cancer using frozen fresh tissue before neoadjuvant chemotherapy. Molecular Medicine. 23:101-111. 2017
- Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial. Lancet, The. 388:2997-3005. 2016
- Efficient gene selection for cancer prognostic biomarkers using swarm optimization and survival analysis. Current Bioinformatics. 11:310-323. 2016